Aspartate decarboxylase and Ribosomal protein S1

Aspartate decarboxylase and Ribosomal protein S1 are distinct molecular entities and should not be grouped as a single target. Aspartate decarboxylase (ADC) is an enzyme that converts L-aspartate to β-alanine, a crucial step for pantothenate and coenzyme A biosynthesis, essential in bacteria. It is a pyruvoyl-dependent enzyme and a potential antimicrobial drug target, with its inhibition by pyrazinoic acid affecting coenzyme A synthesis. Ribosomal protein S1 (S1 or RpsA), conversely, is an essential ribosomal protein in bacteria that binds to and unfolds structured messenger RNAs, facilitating translation. In mycobacteria, S1 is also a target of pyrazinoic acid, and mutations in RpsA are linked to pyrazinamide resistance. Despite both being therapeutic targets, particularly in mycobacterial infections and interacting with pyrazinoic acid, their biochemical functions, molecular classifications, and mechanisms of action are entirely separate.

Other names

Aspartate α-decarboxylaseAspartate 1-decarboxylasePanDS1 ribosomal proteinRpsA

Aspartate decarboxylase functions by converting L-aspartate to β-alanine, essential for coenzyme A biosynthesis, and can be inhibited by drugs affecting this pathway. Ribosomal protein S1 facilitates bacterial translation by binding and unfolding structured mRNAs, and its inhibition impairs protein synthesis. While distinct, both are targets of pyrazinoic acid, affecting different vital bacterial processes.